Introduction
============

The type 2 melastatin-related transient receptor potential channel (TRPM2; formerly called TRPC7 and LTRPC2) is a non-specific cation channel permeable to Na^+^, K^+^ and albeit weakly to Ca^2+^\[[@b1]\]. In addition to the full-length TRPM2 (called TRPM2-L), a short form of TRPM2 (called TRPM2-S), where the four C-terminal trans-membrane domains and the putative pore-forming domain are deleted, have been described. TRPM2 is activated by hydrogen peroxide (H~2~O~2~), a model substance used as a paradigm of oxidative stress. TRPM2 channels are, thus, thought to be sensors for oxidative stress. Reactive oxygen species and oxidative stress have been implicated in the pathogenesis of diabetes. A number of studies have demonstrated that H~2~O~2~ induces β-cell death \[[@b2], [@b3]\]. There is evidence suggesting that TRPM2 mRNA is expressed in human islets \[[@b4]\]. TRPM2 current has been studied mostly in rat insulinoma RIN-5F, and Cambridge rat insulinoma G1 (CRI-G1) cells \[[@b5], [@b6]\]. In these cells, it has been demonstrated that TRPM2 channels are involved in insulin secretion \[[@b5]\]. Moreover, it has been shown that H~2~O~2~-induced death of insulinoma cells is prevented by antisense TRPM2 \[[@b7]\]. However, insulinoma cells of type RIN-5F and CRI-G1 are highly undifferentiated, poorly glucose responsive and thus, show limitations as models of β-cells. A better model of β-cells is INS-1E cells. These are highly differentiated rat insulinoma cells that are currently widely used in experimental diabetes research \[[@b8]\]. It is not known whether INS-1E cells express functional TRPM2 channels. Moreover, TRPM2 proteins have not yet been demonstrated in human β-cells. The main aims of this study were to: (*i*) investigate the role of the TRPM2 channels in H~2~O~2~-induced \[Ca^2+^\]~i~ increase in INS-1E cells; (*ii*) to test N-(p-amylcinnamoyl)anthranilic acid (ACA) as an inhibitor of TRPM2 channels in these cells and (*iii*) to identify the TRPM2 proteins in human islets.

Materials and methods
=====================

Materials
---------

Fura-2 AM was from Invitrogen (Stockholm, Sweden). H~2~O~2~ (30%\[W/W\]), adenosie diphosphate ribose, nimodipine, 2-aminoethoxydiphenyl borate (2-APB) were from Sigma. ACA was from Calbiochem (Stockholm, Sweden). INS-1E cells were from C. B. Wollheim, Geneva, Switzerland.

Cell culture
------------

We used a highly differentiated rat insulinoma cell line INS-1E cells (S5 clone) \[[@b8], [@b9]\]. Glucose-stimulated insulin secretion in these cells is similar to that reported previously \[[@b8], [@b9]\]. The cells were cultured in RPMI-1640 medium, supplemented with 2 mM L-glutamine, 10 mM HEPES, 1 mM sodium pyruvate, 500 μM 2-mercaptoethanol (2-ME), 2.5% foetal bovine serum, 50 i.u./ml penicillin and 50 μg/ml streptomycin.

Isolation and culture of human islets
-------------------------------------

Human islets were provided by the Cell Isolation and Transplantation Centre at the University of Geneva School of Medicine. Use of islets for *in vitro* experiments was approved by the local ethical committee. Islets from three donors were used for experiments. Islets were purified by an automated procedure using a continuous digestion-filtration device \[[@b10], [@b11]\]. Islets were dispersed into single cells by repeated pipetting after digestion in 0.025% trypsin in Ca^2+^- and Mg^2+^-free HBSS. Dispersed cells were cultured on glass cover slips for measurement of \[Ca^2+^\]~i~.

Measurement of \[Ca^2+^\]~i~
----------------------------

Cells cultured on cover slips were incubated in RPMI 1640 containing 0.1% bovine serum albumin (BSA) and 1 μM fura-2 AM for 35 min. The cover slips were then left for 10 min. at room temperature (RT) in a solution containing (in mM) 140 NaCl, 3.6 KCl, 0.5 NaH~2~PO~4~, 0.5 MgSO~4~, 1.5 CaCl~2~, 10 HEPES, 3 glucose and 0.1% BSA (pH 7.4). Nominally Ca^2+^-free medium was prepared by omitting Ca^2+^ from the solution and adding EGTA (0.5 mM). Cover slips were mounted at the bottom of an open perfusion chamber on the stage of an inverted microscope (Olympus CK40, Olympus, Solna, Sweden). The temperature within the chamber was maintained at 37°C. Single cells were studied by using a 40×, 1.3 NA oil immersion objective (40×, UV APO). Cells were excited alternately by 340 and 380 nm wavelengths selected by a monochromator (Photon Technology International, Seefeld, Germany). The emitted light selected by a 510 nm filter was monitored by a photomultiplier tube. The emissions at the excitation wavelengths of 340 nm (*F*340) and 380 nm (*F*380) were used to calculate the fluorescence ratio (*R*340/380). The excitation wavelengths were alternated to obtain one ratio data point per second. The \[Ca^2+^\]~i~ was calculated from *R*340/380 as described before \[[@b12]\]. *R*~max~ and *R*~min~ were determined by using external standard solutions containing fura-2 free acid and sucrose (2M). The *K*~d~ for Ca^2+^-fura-2 was taken as 225 nM.

Recording of TRPM2 current
--------------------------

Cells were analysed with the patch-clamp technique in the whole-cell mode, using an EPC 9 patch-clamp amplifier equipped with a personal computer with Pulse and X chart software (HEKA, Lamprecht, Germany). The extracellular solution contained (in mM) 140 NaCl, 1.2 MgCl~2~, 1.2 CaCl~2~, 5 KCl, 10 HEPES, pH adjusted by NaOH to 7.4. For Na^+^-free solutions, Na^+^ was replaced by 150 mM N-methyl-D-glucamine (NMDG^+^) and pH was titrated with HCl. The pipette solution contained (in mM) 145 Cs-glutamate, 8 NaCl, 2 MgCl~2~, 1 Cs-EGTA, 0.88 CaCl~2~, 10 HEPES, pH adjusted by CsOH to 7.2. This solution contained 1 μM free Ca^2+^. If not otherwise stated cells were held at a potential of --60 mV at 22°C. The current--voltage (I--V) relations were obtained during voltage ramps from --90 to +60 mV applied for 400 ms.

Western blot analysis of human islets
-------------------------------------

Human islets were homogenized in an ice-cold buffer consisting of 150 mM NaCl, 20 mM Tris, pH 7.5, 1% NP40, 1 mM ethylenediaminetetraacetic acid and protease inhibitors. The homogenate was centrifuged at 20,000 rpm for 30 min. at 4°C. The supernatant containing the membrane proteins was collected, and protein concentration was measured by Bio-Rad protein assay kit (Biorad, Sundbyberg, Sweden). A total of 90 μg of protein was fractionated by 10% SDS-polyacrylamide gel electrophoresis and transferred to PVDF membrane. The membranes were blocked by 5% non-fat milk overnight at 4°C, in Tris-buffered saline with Tween-20 (TBS-T). This step was followed by overnight incubation at 4°C with the primary TRPM2 antibodies (dilution 1:300). The primary antibodies were: (*i*) an affinity-purified rabbit polyclonal IgG directed against an epitope on the N-terminal part of TRPM2 (anti-TRPM2-N) (BL 970. Cat. no. A300--414A, Bethyl Laboratories, Inc., Montgomery, TX, USA). (*ii*) Affinity-purified rabbit polyclonal IgG directed against the C-terminal part of the TRPM2 (anti-TRPM2-C) (BL969, Cat. no.A300--413A, Bethyl Laboratories, Inc.). The PVDF membranes were then washed with TBS-T buffer, and incubated with goat anti-rabbit IgG conjugated to horseradish-peroxidase (1:10,000) for 1 hr at RT. Membranes were washed and the immunoreactive bands were detected by enhanced chemiluminescence method and exposure to x-rays film. Antibody specificity was tested by using a blocking peptide (TRPM2 blocking peptide BP969, catalogue no. BP300--413, Bethyl Laboratories, Inc.).

Statistical analysis
--------------------

Data are displayed as mean ± S.E.M., n indicating the number of independent experiments. Student's t-test (unpaired) was used for testing statistical significance and *P* \< 0.05 was accepted as statistically significant.

Results
=======

H~2~O~2~ increased \[Ca^2+^\]~i~ by inducing Ca^2+^ entry through TRPM2 channels
--------------------------------------------------------------------------------

INS-1E cells were cultured in the presence of 2-ME. During the measurement of \[Ca^2+^\]~i~, 2-ME was omitted from the medium. To limit damage to the cells during the experiments, the duration of the experiments was kept as short as possible. To be able to detect relatively small changes in \[Ca^2+^\]~i~, we loaded cells with low concentration of fura-2, because the chelating action of high concentrations of fura-2 makes detection of small \[Ca^2+^\]~i~ changes difficult \[[@b13]\]. We first, established the concentrations of H~2~O~2~ that could increase \[Ca^2+^\]~i~ reproducibly, without causing major damage to the cells. As shown in [Fig. 1A](#fig01){ref-type="fig"}, after the application of H~2~O~2~ (200 μM), \[Ca^2+^\]~i~ increased to a plateau in ∼2--3 min., the magnitude of maximal increase being 29 ± 3 nM (*n*= 16). All \[Ca^2+^\]~i~ changes were confirmed to be true \[Ca^2+^\]~i~ changes, by examining the respective F340 and F380 traces, which moved in opposite directions with change of \[Ca^2+^\]~i~. No \[Ca^2+^\]~i~ change was observed for a period of up to 10 min. in cells where H~2~O~2~ was not applied ([Fig. 1C](#fig01){ref-type="fig"}). After the washout of H~2~O~2~, \[Ca^2+^\]~i~ returned to the baseline indicating that there was no major drift in the baseline ([Fig. 1A](#fig01){ref-type="fig"}). A return of \[Ca^2+^\]~i~ to the basal level also suggested that the cells were not severely damaged by exposure to 200 μM H~2~O~2~. 50 μM H~2~O~2~ increased \[Ca^2+^\]~i~, the magnitude of which was comparable to that obtained with 200 μM H~2~O~2~ ([Fig. 1E](#fig01){ref-type="fig"}). However, \[Ca^2+^\]~i~ increase by 50 μM H~2~O~2~ was more variable compared to that obtained by 200 μM H~2~O~2~ ([Fig. 1E](#fig01){ref-type="fig"}). \[Ca^2+^\]~i~ increases by higher concentrations of H~2~O~2~ (*e.g.* 500 μM and 1 mM) were not completely reversible on washout which suggested persistent activation of the Ca^2+^-entry pathways ([Fig. 1B](#fig01){ref-type="fig"} and D). \[Ca^2+^\]~i~ response to a given concentration of H~2~O~2~ (*i.e.* 200 μM or 500 μM) varied, but on the average, the magnitude of \[Ca^2+^\]~i~ increase obtained by 200 μM H~2~O~2~ was similar to that obtained by 500 μM H~2~O~2~ ([Fig. 1E](#fig01){ref-type="fig"}). For these reasons, we used either 200 μM or 500 μM of H~2~O~2~ in subsequent experiments. As shown in [Fig. 1F](#fig01){ref-type="fig"} and G, H~2~O~2~ (200 μM and 500 μM) increased \[Ca^2+^\]~i~ also in human β-cells.

![H~2~O~2~ increased \[Ca^2+^\]~i~ in INS-1E cells and human β-cells. Cells were perfused with physiological solution containing 3 mM glucose and \[Ca^2+^\]~i~ was measured in fura-2 loaded cells by microfluorometry. (A) H~2~O~2~ (200 μM) increased \[Ca^2+^\]~i~ in a reversible manner (*n*= 16). (B) and (D) \[Ca^2+^\]~i~ increase by 500 μM, (*n*= 24) and 1 mM H~2~O~2~, (*n*= 9) did not completely reverse after washout of H~2~O~2~. (C) baseline \[Ca^2+^\]~i~ remained stable when no H~2~O~2~ was added. (E) the concentration-response curve for H~2~O~2~-induced \[Ca^2+^\]~i~ increase. Data are expressed as percentage of maximal \[Ca^2+^\]~i~ increase obtained by 1 mM H~2~O~2~. Each point represents a mean of 5--24 experiments. (F) and (G) show the effects of H~2~O~2~ on \[Ca^2+^\]~i~ in single human β-cells. H~2~O~2~ increased \[Ca^2+^\]~i~ in 10 out of 12 cells for 200 μM and 4 out of 6 for 500 μM.](jcmm0013-3260-f1){#fig01}

When Ca^2+^ was omitted from the extracellular medium, \[Ca^2+^\]~i~ response to 200 μM H~2~O~2~ was abolished ([Fig. 2B](#fig02){ref-type="fig"} and [C](#fig02){ref-type="fig"}). In these experiments, cells were exposed to nominally Ca^2+^-free medium for 1 min. before addition of H~2~O~2~. In separate experiments, we established that exposure of cells to nominally Ca^2+^-free medium for such short period, did not deplete the ER Ca^2+^ store, because carbachol increased \[Ca^2+^\]~i~ by releasing Ca^2+^ from the ER under such conditions (data not shown). The maximal \[Ca^2+^\]~i~ changes in the Ca^2+^-containing and in the Ca^2+^-free medium were 39 ± 2 nM and --5 ± 10 nM, respectively (*P*= 0.01, *n*= 6). In [Fig. 2D](#fig02){ref-type="fig"}, \[Ca^2+^\]~i~ was first raised by 500 μM H~2~O~2~ in the presence of Ca^2+^-containing extracellular medium. When \[Ca^2+^\]~i~ increased to a plateau, the medium was switched to the nominally Ca^2+^-free medium. This resulted in the return of \[Ca^2+^\]~i~ to the basal level, indicating that the \[Ca^2+^\]~i~ increase by H~2~O~2~ was due to the entry of Ca^2+^ across the plasma membrane ([Fig. 2D](#fig02){ref-type="fig"}, *c.f.*[Fig. 1B](#fig01){ref-type="fig"}).

![H~2~O~2~-induced \[Ca^2+^\]~i~ increase was due to Ca^2+^ entry across the plasma membrane. H~2~O~2~ (200 μM) was applied to INS-1E cells in the presence of 1.5 mM extracellular Ca^2+^ (A) or in nominally Ca^2+^-free medium (B). Maximal \[Ca^2+^\]~i~ change in Ca^2+^ containing medium was 39±2 nM (*n*= 3) and that in nominally Ca^2+^-free medium was --5±10 nM (*n*= 3) (C). In (D), cells were first exposed to H~2~O~2~ (500 μM) in the presence of 1.5 mM extracellular Ca^2+^, and the solution was switched to a nominally Ca^2+^-free medium at the time indicated by the horizontal bar(*n*= 5) (*c.f.*[Fig. 1B](#fig01){ref-type="fig"}).](jcmm0013-3260-f2){#fig02}

\[Ca^2+^\]~i~ increase by H~2~O~2~ (500 μM) was not inhibited by nimodipine (5 μM), a blocker of the L-type voltage-gated Ca^2+^ channels ([Fig. 3A](#fig03){ref-type="fig"} and [B](#fig03){ref-type="fig"}). The maximal \[Ca^2+^\]~i~ increases by H~2~O~2~ in the control group and in the nimodipine group were 27 ± 5 and 23 ± 6 nM, respectively (*P*= 0.63 *n*= 15) ([Fig. 3C](#fig03){ref-type="fig"}). 2-APB (50 μM), a blocker of several TRP channels and some store-operated Ca^2+^ channels, also did not inhibit H~2~O~2~-induced Ca^2+^ entry ([Fig. 3D](#fig03){ref-type="fig"} and [E](#fig03){ref-type="fig"}). The magnitudes of \[Ca^2+^\]~i~ increases in the control group and in the 2-APB group were 13 ± 2 and 14 ± 1 nM, respectively (*P*= 0.75, *n*= 10) ([Fig. 3F](#fig03){ref-type="fig"}). Flufenamic acid and econazole are two inhibitors of TRPM2 \[[@b14], [@b15]\]. We found that both flufenamic acid and econazole increased \[Ca^2+^\]~i~ by themselves and were thus, not suitable for use in further experiments (data not shown). Instead, we tested the effect of ACA, a potent blocker of TRPM2 \[[@b16]\]. In separate experiments, we demonstrated that ACA (20 μM) itself, did not increase \[Ca^2+^\]~i~ in INS-1E cells ([Fig. 3G](#fig03){ref-type="fig"}). As shown in [Fig. 3H](#fig03){ref-type="fig"} (trace a), H~2~O~2~ (200 μM) induced a typical increase of \[Ca^2+^\]~i~ in the control cells. When H~2~O~2~ was applied in the presence of ACA (20 μM), there was no increase of \[Ca^2+^\]~i~ (trace b). Instead, on the average, \[Ca^2+^\]~i~ decreased in the ACA-treated cells, despite continued presence of H~2~O~2~. The maximal changes of \[Ca^2+^\]~i~ by H~2~O~2~ in the absence of, and in the presence of ACA were 23 ± 1 and --9 ± 6 nM, respectively (*P*≤; 0.01, *n*= 6) ([Fig 3I](#fig03){ref-type="fig"}). These observations indicated that the H~2~O~2~-induced Ca^2+^ entry was due to the activation of the TRPM2 channels.

![Effects of different channel blockers on H~2~O~2~-induced \[Ca^2+^\]~i~ increase in INS-1E cells. (A) and (B) Nimodipine did not inhibit H~2~O~2~-induced \[Ca^2+^\]~i~ response. Cells were pre-incubated with Nimodipine (5 μM) for 10 min. H~2~O~2~ (500 μM) was applied in the continued presence of nimodipine (the trace is representative of seven independent experiments). (B) Shows control experiments for (A) (the trace is representative of eight independent experiments). (D) and (E) 2-APB (50 μM) did not alter the \[Ca^2+^\]~i~ response to H~2~O~2~ (200 μM). Cells were treated with 2-APB (50 μM) for 10 min. during pre-incubation and H~2~O~2~ was applied in the continued presence of 2-APB. (E) The control for (A) showing \[Ca^2+^\]~i~ response to H~2~O~2~ in the absence of 2-APB (traces D and E are representatives of three to five independent experiments). (G) ACA (20 μM) did not increase \[Ca^2+^\]~i~ in INS-1E cells. (H) ACA (20 μM) completely inhibited H~2~O~2~-induced \[Ca^2+^\]~i~ response. Trace (a) shows \[Ca^2+^\]~i~ response to H~2~O~2~ (200 μM) in the absence of ACA (the trace is representative of three independent experiments). In trace (b), ACA (20 μM) was applied 1 min. before application of H~2~O~2~ (200 μM) and was continuously present in the perfusion (the trace is representative of three independent experiments). (I) Maximal Ca^2+^ changes by H~2~O~2~ in controls and in the ACA-treated cells were 23 ± 1 and --9 ± 6 nM, respectively (*P* \< 0.01, *n*= 6). In (C), (F) and (I), the bars represent mean \[Ca^2+^\]~i~ increase obtained by H~2~O~2~, expressed as the percentage of maximal \[Ca^2+^\]~i~ increase obtained by 25 mM KCl in respective experiments.](jcmm0013-3260-f3){#fig03}

TRPM2 current in INS-1E cells
-----------------------------

In patch-clamp experiments 0.6 mM ADP ribose was dialysed into the cells through the patch pipette. The pipette solution also contained 1 μM Ca^2+^ to facilitate development of ADP ribose-dependent current \[[@b17]\]. [Figure 4A](#fig04){ref-type="fig"} shows rapid development of inward currents of ∼1 nA after establishment of the whole-cell configuration. The inward currents were minimized when extracellular Na^+^ was substituted by NMDG^+^, which is impermeable through TRPM2. In the absence of ADP ribose, no such current developed, even if cells were infused with pipette solution containing 1 μM Ca^2+^ (see first 150 sec. in the recording of [Fig. 4B](#fig04){ref-type="fig"}). After extracellular application of H~2~O~2~ (∼10 mM), inward currents developed gradually and the currents were immediately suppressed when the bath solution contained NMDG^+^ ([Fig. 4B](#fig04){ref-type="fig"}). The currents could be repeatedly restored by reperfusion with standard bath solution, even when the solution did not contain H~2~O~2~ ([Fig. 4B](#fig04){ref-type="fig"}). After external application of ACA (50 μM), the current gradually declined to almost basal levels. After washout of ACA, currents were partially restored demonstrating that the ACA effect was reversible ([Fig. 4B](#fig04){ref-type="fig"}). The corresponding I--V relation is shown in [Fig. 4C](#fig04){ref-type="fig"}. The H~2~O~2~-evoked currents showed a reversal potential close to 0 mV and inward currents were minimized in the presence of NMDG^+^, which is characteristic for a non-selective cation current (NSCC) like TRPM2.

![Whole-cell currents induced by ADP ribose and H~2~O~2~ in INS-1E cells. The whole-cell configuration was attained at the point indicated with 'w.c.'. Recordings were performed at RT and the holding potential was --60 mV. Bars indicate times where the standard bath solution was changed to a solution containing either NMDG^+^ or the TRPM2 channel inhibitor ACA. (A) Whole-cell current recorded in the presence of intracellular ADP ribose. The pipette solution contained 0.6 mM ADP ribose and 1 μM Ca^2+^. (B) Whole cell currents recorded without ADP ribose and after application of 1--2 μl 30% H~2~O~2~ directly into the recording chamber. The estimated final concentration of H~2~O~2~ in the chamber was ∼10 mM. The pipette solution contained 1 μM free Ca^2+^. (C) Current--voltage relationship of H~2~O~2~-induced currents as derived from (B), recorded during voltage ramps from --90 to +60 mV of 400 ms duration.](jcmm0013-3260-f4){#fig04}

TRPM2 proteins in human islets
------------------------------

We performed Western blotting with membrane preparations from human islets. The blot was probed with anti-TRPM2-N and anti-TRPM2-C antibodies. The immunogen for anti-TRPM2-N was the peptide ILKELSKEEEDTDSSEEMLA, which represents the amino acids 658--677 of human TRPM2 encoded within exon 13. The immunogen for anti-TRPM2-C was the peptide KAAEEPDAEPGGRKKTEEPGDS, which represents amino acids 1216--1237 of human TRPM2 encoded within exon 25. In Western blotting of human islets ∼171 kD bands representing TRPM2-L were detected by both anti-TRPM2-N ([Fig. 5A](#fig05){ref-type="fig"}) and anti-TRPM2-C antibodies ([Fig. 5A1](#fig05){ref-type="fig"}). As expected, a ∼95 kD band representing the TRPM2-S was detected by the anti-TRPM2-N antibody ([Fig. 5A](#fig05){ref-type="fig"}) but not by the anti-TRPM2-C antibody ([Fig. 5A1](#fig05){ref-type="fig"}). In control experiments we found that the ∼75 kD bands were non-specific ones, because they were detected even when the membranes were treated with the corresponding blocking peptides.

![Western blot analysis of TRPM2 proteins in human islets. A total of 90 μg of membrane proteins from human islets were separated in two lanes (A, A1) by 10% SDS-PAGE electrophoresis. In A, the blots were probed with an anti-TRPM2-N antibody (1:300). In A1, the blots were probed with an anti-TRPM2-C antibody (1:300). Standard proteins are shown on the right side. The experiments have been repeated at least three times with similar results.](jcmm0013-3260-f5){#fig05}

Discussion
==========

Effects of H~2~O~2~ on \[Ca^2+^\]~i~ changes in INS-1E cells have been reported before \[[@b2]\]. However, it remained unknown whether H~2~O~2~ can trigger Ca^2+^ influx in these cells, and in that case, what could be the identity of the Ca^2+^ influx pathways. The emergence of TRPM2 as a H~2~O~2~-sensitive channel prompted us to examine if TRPM2 could be a link between H~2~O~2~ and \[Ca^2+^\]~i~ increase in INS-1E cells. We demonstrate that a short (∼5 min.) exposure of H~2~O~2~ (50--500 μM) to INS-1E cells, increased \[Ca^2+^\]~i~ solely by inducing Ca^2+^ entry across the plasma membrane. This was evident from the observation that no \[Ca^2+^\]~i~ increase by H~2~O~2~ was observed when Ca^2+^ was omitted from the extracellular medium. H~2~O~2~ activates TRPM2 by acting on the cytoplasmic side of the channel \[[@b18]\]. Externally applied H~2~O~2~ does not freely pass through the plasma membrane \[[@b19]\]. For this reason, and because of the presence of catalase in the cytoplasm, the effective cytoplasmic concentration of H~2~O~2~ that increased \[Ca^2+^\]~i~ in our experiments, is likely to be lower. The high \[Ca^2+^\]~i~ increase caused by 1 mM H~2~O~2~ is due to multiple non-specific mechanisms including the release of Ca^2+^ from the mitochondria and the ER, as has been described before \[[@b20], [@b21]\]. In our study, H~2~O~2~-activated Ca^2+^ entry was not blocked by nimodipine, indicating that the L-type voltage-gated Ca^2+^ channels did not mediate the Ca^2+^ entry. Moreover, 2-APB did not block the Ca^2+^ entry suggesting a lack of involvement of some of the store-operated Ca^2+^ channels or the inositol 1,4,5 trisphosphate receptor \[[@b22]\]. As an inhibitor of TRPM2-channel, the role of 2-APB remains controversial \[[@b23], [@b24]\]. On the other hand, H~2~O~2~-induced Ca^2+^ entry was completely blocked by ACA, a potent blocker of TRPM2 channel \[[@b16]\]. In fact, in ACA-treated cells there was, on the average, a small decrease in \[Ca^2+^\]~i~ suggesting some basal activity of TRPM2 channels at 37°C. ACA, however, is not entirely specific for TRPM2, because it also blocks TRPM8 and TRPC6 \[[@b16]\]. Nevertheless, Ca^2+^ entry that is induced by H~2~O~2~ and ADP ribose, and is blocked by ACA is most likely to be mediated through the TRPM2 channels.

ACA has generally been used as an inhibitor of phospholipase A~2~ (PLA~2~), which plays an important role in mediating insulin secretion and \[Ca^2+^\]~i~ oscillations in β-cell \[[@b25]--[@b29]\]. However, in our experiments, activation of TRPM2 by H~2~O~2~ did not involve activation of PLA~2~. This is evident from the observation that H~2~O~2~ activated TRPM2 current, even when cells were internally dialysed and the recordings were performed at 22°C ([Fig. 4B](#fig04){ref-type="fig"}). In fact, it is known that H~2~O~2~ does not activate PLA~2~, rather it inhibits the enzyme \[[@b30]\]. Given that ACA is now established as a potent blocker of TRPM2, caution is needed in interpreting previous reports where ACA was used as the sole inhibitor of PLA~2~. Another inhibitor of PLA~2~, namely AACOCF~3~ does not inhibit TRPM2 \[[@b16]\]. However, AACOCF~3~ was not suitable for use in our experiments, because it is oxidized by H~2~O~2~.

Consistent with H~2~O~2~-induced \[Ca^2+^\]~i~ increase, we recorded NSCC induced by H~2~O~2~ and ADP ribose in INS-1E cells. The NSCC was carried mainly by Na^+^ in the inward direction. Such Na^+^ currents were minimized by NMDG^+^, in spite of the presence of 1.2 mM Ca^2+^ in the external solution. In a previous study, we demonstrated that very small Ca^2+^ currents could be detected when external Na^+^ was replaced by NMDG^+^, even when the external Ca^2+^ concentration was raised to 10 mM \[[@b18]\]. The contribution of Ca^2+^ to the overall currents was not resolved in the experiments shown in [Fig. 4](#fig04){ref-type="fig"}. It is known from previous studies that Ca^2+^ is only weakly permeable through TRPM2 channel, the permeability ratio p~Ca~:p~Na~ being ∼0.6--0.7 \[[@b31]\]. However, the permeability of Ca^2+^ measured in the presence of high extracellular Ca^2+^ can lead to an underestimation of Ca^2+^ fluxes under physiological conditions \[[@b32]\]. Functionally, the importance of the Ca^2+^ fluxes through the TRPM2 channels is evident from the increase in \[Ca^2+^\]~i~ detected by fura-2 after activation of TRPM2 by H~2~O~2~. In patch-clamp experiments, we also used 0.6 mM ADP ribose together with 1 μM free Ca^2+^. This protocol allowed rapid development of a sizable current after attaining the whole-cell configuration ([Fig. 4A](#fig04){ref-type="fig"}). In contrast, the development of currents after extracellular application of H~2~O~2~, even in the presence of intracellular Ca^2+^, was delayed. Such delay may be due to the fact that H~2~O~2~ does not gate TRPM2 directly, rather it may act by increasing the concentration of intracellular ADP ribose \[[@b33], [@b34]\]. The activation of TRPM2 currents by H~2~O~2~ was long lasting and persisted even after wash out of H~2~O~2,~ an observation consistent with previous reports \[[@b18], [@b31]\]. After substitution of the NMDG^+^-containing bath solution (which suppressed inward currents) with normal bath solution (which supported inward currents) the inward currents increased immediately to the maximal level. This indicated that the channel activation persisted after the initial exposure to H~2~O~2~. In contrast, the release from ACA-block showed much slower kinetics, an observation consistent with a decrease in the open probability of the channel by ACA \[[@b16]\]. Thus, we have demonstrated an inward current that is activated by ADP-ribose ([Fig. 4A](#fig04){ref-type="fig"}) and by H~2~O~2~ ([Fig. 4B](#fig04){ref-type="fig"}) and is inhibited by ACA. This pharmacological profile establishes that the current is mediated through the TRPM2 channels.

Furthermore, by Western blotting, we have demonstrated for the first time, the presence of TRPM2 proteins in human islets. By using anti-TRPM2-N and anti-TRPM2-C antibodies, we identified two isoforms of TRPM2 in these cells \[[@b35]\]. The anti-TRPM2-N antibody detected not only the full length TRPM2-L, but also the C-terminally truncated TRPM2-S, in human islets. TRPM2-S isoform appeared as a ∼95 kD band detected by the anti-TRPM2-N, and not by the anti-TRPM2-C. TRPM2-S itself does not form a channel but instead it acts as a dominant negative of TRPM2-L \[[@b35]\]. Thus, human β-cells have not only the H~2~O~2~-sensitive isoform but also the protective isoform of TRPM2. The relative abundance of these isoforms may determine the extent of H~2~O~2~-induced TRPM2-mediated Ca^2+^ influx \[[@b36]\].

Previous studies have examined the effects of H~2~O~2~ on insulin secretion, \[Ca^2+^\]~i~ changes, membrane potential changes, glucose metabolism, mitochondrial metabolism and β-cell death \[[@b2], [@b20], [@b21], [@b37]\]. It is evident from these reports that exposure of β-cells to relatively high concentration of H~2~O~2~ for prolonged period inhibits metabolism, leading to opening of the K~ATP~ channels, hyperpolarization of membrane potential and inhibition of insulin secretion \[[@b2], [@b20]\]. More recently, Pi *et al.* demonstrated that 1--4 μM H~2~O~2~ induces insulin release from INS-1 cells suggesting that H~2~O~2~ may act as a signal for insulin secretion \[[@b3]\]. These investigators used a clone of INS-1 cells which is different from ours. The authors did not report whether 1--4 μM H~2~O~2~ increased \[Ca^2+^\]~i~ in their clone of INS-1 cells. Maechler *et al.* demonstrated that the threshold concentration of H~2~O~2~ for insulin secretion from INS-1E cells was 200 μM, a concentration that invariably increased \[Ca^2+^\]~i~ in our experiments \[[@b2]\]. However, in our patch-clamp experiments, we used 10 mM H~2~O~2~ to obtain a large current that displays a fingerprint of current properties of TRPM2 channel. Even when TRPM2 current was activated by 10 mM H~2~O~2~, the current could be completely blocked by ACA. TRPM2 is a temperature sensitive channel and its regulation by temperature has been studied by Togashi *et al.*\[[@b5]\]. Whereas, our microfluorometry experiments were performed at 37°C, the patch-clamp experiments were done at 22°C for technical reasons. It may be mentioned that patch-clamp experiments are performed under conditions that are not strictly physiological, and it is often necessary to use 10 mM H~2~O~2~ for inducing TRPM2 currents in native cells when experiments are performed at 22°C \[[@b18], [@b37]\]. However, in transfected cells where TRPM2 is overexpressed, a sizable current can often be detected by micromolar H~2~O~2~\[[@b7]\].

In summary, we have demonstrated that in INS-1E cells, H~2~O~2~ (50--500 μM) applied for a short period (5--10 min.) increased \[Ca^2+^\]~i~ by triggering Ca^2+^ entry through the TRPM2 channels. Consistent with this, H~2~O~2~- and ADP ribose-activated TRPM2 current was detected in INS-1E cells. By Western blotting, two major isoforms of TRPM2 were identified in human islets. It has been demonstrated that glucose increases production of H~2~O~2~ in INS-1(832/13) cells \[[@b3]\]. However, we demonstrate that concentrations of H~2~O~2~ that could be relevant from signalling point of view (*e.g.* 1--4 μM) fail to activate TRPM2 channel. Nevertheless, given the known roles of TRPM2 channels in redox- and cytokine-mediated cell death, these channels may be of relevance in the pathogenesis of type 1 and type 2 diabetes, where β-cell damage contributes to the disease process. Inhibitors of TRPM2 channels are thus, of potential interest as therapeutic agents.
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